Quality of life in children with chronic kidney disease (with child and parent assessments)

Buyan, Necla; Türkmen, Mehmet; Bilge, Ilmay; Baskin, Esra; Haberal, Mehmet; Bilginer, Yelda; Mir, Sevgi; Emre, Sevinç; Akman, Sema; Ozkaya, Ozan; Fidan, Kibriya; Alpay, Harika; Kavukcu, Salih; Sever, Lale; Özçakar, Zeynep; Dogrucan, Nahide
August 2010
Pediatric Nephrology;Aug2010, Vol. 25 Issue 8, p1487
Academic Journal
Herein the results of a multicenter study from the Turkish Pediatric Kidney Transplantation Study Group are reported. The aims of this study were to compare the quality of life (QoL) scores of Turkish children who are dialysis patients (DP), renal transplant recipients (TR), and age-matched healthy controls and to compare child-self and parent-proxy scores. The Turkish versions of the Kinder Lebensqualität Fragebogen (KINDL®) questionnaires were used as a QoL measure. The study group consisted of 211 children and adolescents with chronic kidney disease (CKD) (139 TR and 72 DP aged between 4–18 years; 13.7 ± 3.5 years) from 11 university hospitals, 129 parents of these patients, 232 age-matched healthy children and adolescents (aged between 4–18 years; 13.1±3.5 years) and 156 of their parents. Patients with CKD had lower scores in all subscales except for physical well-being than those in the control group. TR had higher scores in physical well-being, self-esteem, friends’ subscales, and total scores than DP. Child-self scores were lower than parent-proxy scores, especially in CKD, DP, and control groups. Concordance between parent-proxy and child-self reports in the TR, DP, CKD, and control groups was only moderate for the majority of subscales ( r = 0.41–0.61). It was concluded that parent-proxy scores on the QoL were not equivalent to child-self scores and that evaluating both children’s and parents’ perspectives were important. Additionally, psychosocial counseling is crucial not only for patients with CKD but also for their parents.


Related Articles

  • Aortic stiffness in ESRD children before and after renal transplantation. Aoun, Bilal; Lorton, Fleur; Wannous, Hala; Lévy, Bernard; Ulinski, Tim // Pediatric Nephrology;Jul2010, Vol. 25 Issue 7, p1331 

    Cardiovascular complications are the main cause of death in end-stage renal failure in adult patients, but those complications start in childhood. Renal transplantation (RT) seems to reduce or even reverse certain abnormalities seen in dialyzed patients. Since RT seems to correct metabolic...

  • Chronic renal insufficiency in children and adolescents: the 1996 annual report of NAPRTCS. Fivush, Barbara A.; Jabs, Kathy; Neu, Alicia M.; Kenneth Sullivan, E.; Feld, Leonard; Kohaut, Edward; Fine, Richard // Pediatric Nephrology;1998, Vol. 12 Issue 4, p328 

    The 1996 annual report of the Chronic Renal Insufficiency Arm of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) summarizes descriptive data and highlights important features on 1,725 patients from 130 centers. This database contains information on patients with an...

  • Chronic dialysis in children and adolescents. The 2001 NAPRTCS Annual Report. Neu, Alicia M.; Ho, P. L. (Martin); McDonald, Ruth A.; Warady, Bradley A. // Pediatric Nephrology;Aug2002, Vol. 17 Issue 8, p656 

    The 2001 annual report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) registry includes data on 4,546 dialysis patients. Important trends in dialysis care include a significant increase in the use of peritoneal dialysis catheters with two cuffs (51.6% vs. 36.2%,...

  • Post graft development of short children treated with growth hormone before kidney graft. Simon, D.; Rosilio, Myriam; Maisin, Anne; Remesy, Michel; Baudouin, Véronique; Loirat, Chantal; Czernichow, Paul // Pediatric Nephrology;1999, Vol. 13 Issue 9, p723 

    Sixteen prepubertal patients with chronic renal failure (CRF) were given daily recombinant human growth hormone (rhGH) treatment (1.2 IU/kg per week) for 2.6±1.6 years until kidney transplant. Therapy was then discontinued and the patients followed for a further 3.5±1.4 years. During...

  • Renal transplantation in children with posterior urethral valves. Mendizabal, Santiago; Zamora, Isabel; Serrano, Agustin; Sanahuja, Maria Jose; Roman, Ezena; Dominguez, Carlos; Ortega, Pedro; García Ibarra, Fernando // Pediatric Nephrology;Apr2006, Vol. 21 Issue 4, p566 

    The objective of this study was to analyze whether renal transplantation (RT) in children with posterior urethral valves (PUV) constitutes a special group with respect to groups with different etiologies of end-stage renal disease (ESRD). Between 1979 and 2004, 22 RT were performed in 19...

  • Long-term follow-up of growth in children post-transplantation. Tejani, Amir; Sullivan, Kenneth // Kidney International Supplement;Oct1993, Issue 43, pS56 

    With improving graft survival, growth post-transplantation, demands increasing attention from pediatric transplant physicians. As our database matures, the North American Pediatric Renal Transplant Cooperative Study is able to track growth patterns longitudinally. Of 2086 patients enrolled in...

  • Growth hormone in the treatment of growth failure in children after renal transplantation. Benfield, Mark R.; Parker, Kathrina L.; Waldo, F. Bryson; Overstreel, Sandra; Kohaut, Edward C. // Kidney International Supplement;Oct1993, Issue 43, pS62 

    Growth failure continues to be a problem in the management of children with renal failure. Children have improved growth after successful renal transplantation, but seldom have ‘catch-up’ growth, or normal adult height. Several investigators have reported the use of rhGH in children...

  • Growth hormone treatment of growth failure among children with renal transplants. Jabs, Kathy; Van Dop, Cornelis; Harmon, William E. // Kidney International Supplement;Oct1993, Issue 43, pS71 

    Eight children with growth failure following renal transplant have been selected for recombinant human growth hormone (rhGH) treatment at Children's Hospital using the following criteria: (1) a functioning allograft for at least one year: (2) height < third percentile; (3) growth velocity < 4...

  • Predictors of growth response to rhGH in short children before and after renal transplantation. Wuhl, Elke; Haffner, Dieter; Tonshoff, Burkhard; Mehls, Otto // Kidney International Supplement;Oct1993, Issue 43, pS76 

    Many children with chronic renal failure (CRF) present with a reduced height and a reduced height velocity resulting in diminished final height irrespective of renal replacement therapy. Recombinant human growth hormone (rhGH) has become a new treatment modality for short renal patients, and the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics